Editas Medicine, Inc. (EDIT) CEO Cindy Collins on Q3 2019 Results Earnings Call - TranscriptSeeking Alpha • 11/12/19
Editas Medicine and Celgene Corporation Amend Existing Collaboration to Develop and Commercialize Autologous and Allogeneic T Cell Medicines for the Treatment of Cancer and Autoimmune DiseasesGlobeNewsWire • 11/12/19
Editas Medicine and AskBio Enter Strategic Research Collaboration to Explore In Vivo Delivery of Genome Editing Medicines to Treat Neurological DiseasesGlobeNewsWire • 10/15/19
Editas Medicine and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Cell MedicinesGlobeNewsWire • 10/07/19
Editas Medicine, Inc. (EDIT) CEO Cindy Collins on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/07/19
Editas Medicine (EDIT) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 07/29/19